- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Zydus Lifesciences Limited — Updates, 09-12-2025: Press Release
09-12-2025 | 05:30 pm
09-12-2025 | 05:30 pm
Zydus Lifesciences' subsidiary partnered with Formycon for exclusive US & Canada commercialization of FYB206, a Keytruda biosimilar. This strategic move marks Zydus' entry into the North American biosimilar market, leveraging its recently acquired manufacturing facilities for affordable oncology care.
No comments yet. Be the first to comment!